HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
1.255
-0.050 (-3.83%)
At close: Jun 20, 2025, 4:00 PM
1.290
+0.035 (2.79%)
After-hours: Jun 20, 2025, 4:00 PM EDT
HOOKIPA Pharma Stock Forecast
HOOK's stock price has decreased by -82.23% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts that cover HOOKIPA Pharma stock have a consensus rating of "Buy" and an average price target of $10.67, which forecasts a 750.2% increase in the stock price over the next year. The lowest target is $2 and the highest is $23.
Price Target: $10.67 (+750.2%)
Analyst Consensus: Buy
* Price targets were last updated on Dec 20, 2024.
Analyst Ratings
The average analyst rating for HOOKIPA Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 10, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $48 → $2 | Buy → Hold | Downgrades | $48 → $2 | +59.36% | Dec 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $24 → $7 | Buy | Maintains | $24 → $7 | +457.77% | Nov 21, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $50 → $48 | Buy | Maintains | $50 → $48 | +3,724.70% | Nov 15, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +1,812.35% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
25.50M
from 43.95M
Decreased by -41.97%
Revenue Next Year
1.02M
from 25.50M
Decreased by -96.00%
EPS This Year
-2.29
from -3.47
EPS Next Year
-1.59
from -2.29
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 26.3M | 1.1M | 10.5M |
| Avg | 25.5M | 1.0M | 10.2M |
| Low | 24.5M | 980,000 | 9.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -40.3% | -95.9% | 929.4% |
| Avg | -42.0% | -96.0% | 900.0% |
| Low | -44.2% | -96.2% | 860.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.99 | -1.64 | -1.31 | ||
| Avg | -2.29 | -1.59 | -1.28 | ||
| Low | -2.55 | -1.53 | -1.23 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.